Sep 2011
Sep 2011Publications 2000-2005
MORU Publications 2000 - 2005
(Excluding Abstracts)
495. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, Whitworth J, Velez ID, Brockman AH, Nosten F, Ferreira MU, Day KP. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol, 2000; 17: 1467-82.
496. Angus BJ, Smith MD, Suputtamongkol Y, Mattie H, Walsh AL, Wuthiekanun V, Chaowagul W, White NJ. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion versus intermittent bolus injection in septicaemic melioidosis. Brit J Clin Pharm, 2000; 50: 184-191.
497. Anuntagool N, Aramsri P, Panichhakul T, Wuthiekanun V, Kinoshita R, White NJ, Sirisinha S.Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates.Southeast Asian J Trop Med Public Health, 2000; 31:146-152.
498. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F. Plasmodium falciparum antimalarial drug susceptibility on the northwestern border of Thailand during five years of extensive use of artesunate-mefloquine. Trans RSoc Trop Med Hyg, 2000, 94:537-544.
499. Chotivanich K, Dondorp AM, White NJ, Peters K, Vreeken J, Kager PA, Udomsangpetch R. The resistance to physiological shear stresses of the erythrocytic rosettes formed by cells infected with Plasmodium falciparum. Ann Trop Med Parasitol, 2000; 94: 219-226.
500. Chotivanich K, Udomsangpetch R, Simpson JA, Newton P, Pukrittayakamee S, Looareesuwan S, White NJ. Parasite multiplication potential and the severity of falciparum malaria. J Infect Dis, 2000; 181: 1206-9.
501. Chotivanich K, Udomsangpetch R, Dondorp A, Williams T, Angus B, Simpson JA, Pukrittayakamee S, Looareesuwan S, Newbold CI, White NJ. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis. 2000; 182: 629-633.
502. Davis TME, Supanaranond W, Pukrittayakamee S, Holloway P, Chubb P, White NJ.Progression of skeletal muscle damage during treatment of severe falciparum malaria.Acta Tropica, 2000; 76:271-276.
503. Dondorp AM, Kager PA, Vreeken J, White NJ. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol Today, 2000; 16:228-232.
504. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. The pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute uncomplicated falciparum malaria. Antimicrob Agents Chemother, 2000; 44: 697-704.
505. Green,MD, Mount, DL, Wirtz, RA, White, NJ. A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate.J Pharm BiomedAnal 2000; 24: 65-70.
506. Ho M, Hickey MJ, Murray AG, Andonegui G, Kubes P.Visualization of Plasmodium falciparum – Endothelium interactions in human microvasculature: Mimicry of leukocyte recruitment.J. Exp. Med, 2000; 192:1205-1211.
507. Koonpaew S, Ubol MN, Sirisinha S, White NJ, Chaiyaroj SC.Genome fingerprinting by pulsed-field gel electrophoresis of isolates of Burkholderia pseudomallei from patients with melioidosis in Thailand.Acta Tropica, 2000; 74: 187-91.
508. Lauw FN, Simpson AJ, Prins JM, van Deventer SJ, Chaowagul W, White NJ, van Der Poll T. The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe mlioidosis.Infect Immun. 2000; 68: 3888-3893.
509. Lauw FN, Simpson AJ, Hack CE, Prins JM, Wolbink AM, van Deventer SJ, Chaowagul W, White NJ, van Der Poll T. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to Gram-negative bacteria. J Infect Dis. 2000; 182: 206-213.
510. Mayxay M, Newton P, White NJ.General chemotherapy of malaria.Postgrad Doctor, 2000; 16:382-388.
511. McGready R, Paw E, Nosten F. Menorrhagia caused by dengue fever. Aust N Z J Obstet Gynaecol 2000; 40; 354-5.
512. McGready R, Simpson J, Panyavudhikra S, Loo S, Mercuri E, Haataja L, Kolatat T, Nosten F, Dubowitz, L. Neonatal neurological testing in resource-poor settings. Ann Trop Paediat 2000 ; 20 ; 3-336.
513. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multi-drug resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg, 2000; 94: 689-693.
514. Newton P, Suputtamongkol Y, Teja-Isavadharm P, Pukrittayakamee S, Navaratnam V, Bates I, White NJ. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob Agents Chemother, 2000; 44: 972-977.
515. Nontprasert A, Pukrittayakamee S, Nosten-Bertrand M, Vanijanonta S, White NJ. Studies of the neurotoxicity of oral artemisinin derivatives in mice. Am J Trop Med Hyg, 2000; 62: 409-412.
516. Nosten F, van Vugt M, Price R, Luxemburger C, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ. Effects of artesunate-mefloquine combination on incidence of Plasmodium .falciparum malaria and mefloquine resistance in western Thailand. Lancet, 2000; 356: 297 - 302.
517. Pukrittayakamee S, Chantra A, Simpson JA, Vanijanonta S, ClemensR, Looareesuwan S, White NJ. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother, 2000; 44:1680-1685.
518. Pukrittayakamee S, Chantra A, Vanijanonta S, Clemens R, Looareesuwan S, White NJ. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother. 2000; 44: 2395-2398.
519. Simpson AJH, Wuthiekanun V. Interaction of insulin with Burkholderia pseudomallei may be due to a preservative. J Clin Path, 2000; 53:159-160.
520. Simpson AJH, Opal SM, Angus BJ, Prins JM, Palardy JE, Parejo NA, Chaowagul W, White NJ. Differential antibiotic-induced endotoxin release in severe melioidosis. J Infect Dis, 2000; 181: 1014-1019.
521. Simpson AJH, Smith MD, Weverling GJ, Suputtamongkol Y, Angus BJ, Chaowagul W, White NJ, van Deventer SJH, Prins JM. Prognostic value of cytokine concentrations (tumor necrosis factor, interleukin 6 and interleukin 10) and clinical parameters in severe melioidosis. J Infect Dis, 2000; 181: 621-625.
522. Simpson AJH, Dance DAB, Wuthiekanun V, White NJ. Serum bactericidal and inhibitory titres in the management of melioidosis. J Antimicrob Chemother, 2000; 45:123-127.
523. Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Antimicrob Agents Chemother, 2000; 44:3414-3424.
524. Suputtamongkol Y, Intaranongpai S, Smith MD, Angus BJ, Chaowagul W, Permpikul C, Simpson JA, Leelarasamee A, Curtis L, White NJ.A double blind placebo-controlled study of an infusion of lexipafant (platelet activating factor receptor antagonist) in patients with severe sepsis. Antimicrob Agents Chemother, 2000; 44: 693-696.
525. van Vugt M, Angus BM, Price RN, Mann C, Simpson JA, Poletto C, Eh Htoo, Looareesuwan S, White NJ, Nosten F. A case-control auditory evaluation of patients treated with artemisinin derivatives for multi-drug resistant Plasmodium falciparum malaria. Am J Trop Med Hyg, 2000; 62: 65-69.
526. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F.Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.Trans R Soc Trop Med Hyg, 2000; 94:545-548.
527. White NJ. Melioidosis. In GT Strickland ed. Hunter's Tropical Medicine. Philadelphia, WB Saunders Co, 2000; 37:313-316.
528. White NJ. Neurological dysfunction following malaria: disease- or drug-related? Clinical Infectious Diseases, 2000; 30:836.
529. Yipp BG, Samantha A, Schollaardt T, Patel KD, Looareesuwan S, Ho M.Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum – infected erythrocytes to microvascular endothelial cells under flow.Blood, 2000; 96:2292-2298.
530. The Artemether–Quinine Meta-analysis Study Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 2001; 95: 637-650.
531. Chotivanich K, Silamut K, Udomsangpetch R, Stepniewska K, Pukrittayakamee S, Looareesuwan S, White, NJ.Ex-vivo short term culture and developmental assessment of Plasmodium vivax.Trans R Soc Trop Med Hyg, 2001;95:677-680.
532. Etchegorry MG, Matthys F, Galinski M, White NJ, Nosten F.Malaria epidemic in Burundi.Lancet. 2001; 357: 1046-7.
533. Imwong M, Pukrittayakamee S, Looareesuwan S, Pasvol G, Poirriez J, White NJ, Snounou G.Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulphadoxine/pyrimethamine: geographical and clinical correlates.Antimicrob Agents Chemother 2001; 45:3122-3127.
534. Imwong M, Pukrittakayamee S, Looareesuwan S, Poirriez J, Pasvol G, White NJ, Snounou G. Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker. Exp Parasitol. 2001; 99:175-9.
535. Leonardi Nield E, Gilvary G, White NJ, Nosten F.Severe allergic reactions to oral artesunate.Trans R Soc Trop Med Hyg2001; 95:182-183.
536. Luxemburger C, McGready R, Kham A, Morison L, Cho T, Chongsuphajaisiddhi T, White NJ, Nosten F.Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission.Am J Epidemiol. 2001; 154:459-465.
537. Mayxay M, Pukrittayakamee S, Chotivanich K, Looareesuwan S, White NJ.Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans R Soc Trop Med Hyg, 2001; 95:179-182.
538. Mayxay M, Pukrittayakamee S, Chotivanich K, Imwong M, Looareesuwan S, White NJ.Identification of cryptic co-infection with Plasmodium falciparum in patients presenting with vivax malaria.Am J Trop Med 2001; 65:588-592.
539. Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S, White NJ.The contribution of humoral immunity to the therapeutic response in falciparum malaria.Am J Trop Med Hyg, 2001; 65: 918-23.
540. McGready R, Simpson JA, Htway M, Nosten F, White NJ, Lindsay SW. A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 2001; 95: 137-8.
541. McGready R, Hamilton KA, Simpson JA, Cho T, Luxemburger C, Edwards R, Looareesuwan S, White NJ, Nosten F, Lindsay SW. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg. 2001; 65: 285-9.
542. McGready R, Cho T, Keo, NK, Villegas L, Looareesuwan S, White NJ, Nosten F, White NJ. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 multidrug resistant P.falciparum episodes. Clin Infect Dis. 2001; 33: 2009-16.
543. McGready R, Simpson JA, Cho T, Dubowitz L, Changbumrung S, Bohm V, Munger RG, Sauberlich HE, White NJ, Nosten F. Postpartum thiamine deficiency in a Karen displaced population. Am J Clin Nutr 2001; 74: 808-13.
544. McGready R, Cho T, Samuel Villegas L Brockman A, van Vugt M, Looareesuwan S, White NJ, Nosten F. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of multi-drug resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg, 2001; 95: 651-6.
545. Newton P, Simpson A, Wanwimolruk S, Maliakal P, Villegas L, Kuypers D, White NJ.Oral quinine pharmacokinetics and dietary salt intake.Euro J Clin Phar 2001; 57: 111-113.
546. Newton P, Chierakul W, Ruangveerayuth R, Silamut K, Teerapong P, Krudsood S, Looareesuwan S, White NJ.A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria Trans R Soc Trop Med Hyg 2001; 95: 519-523.
547. Newton P, Chotivanich K, Chierakul W, Ruangveerayuth R, Teerapong P, Silamut K, Looareesuwan S, White NJ.A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen (RESA) positive and negative erythrocytes.Blood 2001; 98: 450-457.
548. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Chotvanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ.Fake artesunate in Southeast Asia.Lancet 2001; 357: 1948-1950.
549. Paton NI, Angus B, Chaowagul W, Simpson AJ, Suputtamongkol Y, Elia M, Calder G, Milne E, White NJ, Griffin GE. Protein and energy metabolism in chronic bacterial infection: studies in melioidosis. Clin Sci 2001; 100: 101-110.
550. Phetsouvanh R, Phongmaany S, Newton P, Mayxay M, Ramsay A, Wuthiekanun W, White NJ. Melioidosis and Pandora's box in Lao PDR. Clin Infect Dis, 2001; 32: 653-654.
551. Pitisuttithum P, Tansuphasawadikul S, Simpson AJH, Howe PA, White NJ.A Prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.J Infect 2001; 43, 226-233.
552. Price RN, Simpson J, Nosten F, Luxemburger C, Hkirijaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Factors contributing to anemia in uncomplicated falciparum malaria. Am J Trop Med Hyg, 2001; 65: 614-22.
553. Price RN, Nosten F. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist Updat. 2001; 4:187-96.
554. Proux S, Hkirijareon L, Ngamngonkiri C, McConnell S, Nosten F. Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria. Trop Med Int Health. 2001; 6: 99-101.
555. Pukrittayakamee S, Clemens R, Chantra A, Nontprasert A, Luknam T, Looareesuwan S, White NJ.Therapeutic responses to antibacterial drugs in vivax malaria.Trans R Soc Trop Med Hyg.2001;95: 524-528.
556. Rowland M, Nosten F.Malarial epidemiology and control in refugee camps and complex emergencies.Annal Trop Med Parasitol 2001; 95: 741-754.
557. Simpson AJH. Melioidosis: a clinical model for Gram-negative sepsis. J Med Microbiol 2001; 50: 657-8.
558. Simpson JA, Aarons L, White NJ.How can we do pharmacokinetic studies in the tropics?Trans R Soc Trop Med Hyg.2001; 95:347-351.
559. Sitprija V, Newton P.Leptospirosis. In: Concise Oxford Textbook of Medicine, Oxford University Press, 2001.
560. Suputtamongkol Y, Newton P, Angus B, Teja-Isavadharm P, Keeratithakul D, Rasameesoraj M, Pukrittayakamee S, White NJ.A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.Br J Clin Pharm 2001; 52: 655-661.
561. Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pecoul B. Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health 2001; 6: 945-51.
562. White NJ, Breman JG. Diseases caused by red blood cell parasites;Malaria and Babesiosis. In:Fauci AS, Martin JB, Braunwald E, Kasper DL, Isselbacher KJ, Hauser SL, Wilson JD, Longo DL eds. Harrison's Principles of Internal Medicine. 15th edition. New York: McGraw?Hill Inc., 2001.
563. Wuthiekanun V, Suputtamongkol Y, Simpson AJH, Kanaphun P, White NJ.The value of the throat swab in the diagnosis of melioidosis.J Clin Micro 2001; 39:3801-3802.
564. Angus BJ, Thiaporn I, Chanthapadit K, Suputtamongkol Y, White NJ. Oral artesunate dose response relationship in acute falciparum malaria. Antimicrob Agents Chemother 2002; 46: 778-782.
565. Bussaratid V, Tansupasawasdikul S, Simpson A, Pitisuttithum P, Phonrat B, Howe P, White NJ. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients. J Med Assoc Thai 2002; 85: 757-64.
566. Chotivanich K, Udomsangpetch R, McGready R. Proux S, Newton P, Pukrittayakamee S, Looareesuwan S, White NJ. The central role of the spleen in malaria parasite clearance. J Infect Dis 2002; 185: 1538-41.
567. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson JA, Looareesuwan S, White NJ. Hemoglobin E; a balanced polymorphism protective against high parasitemias and thus severe falciparum malaria. Blood; 2002, 100: 1172-1176.
568. Desakorn V, Simpson AJH, Wuthiekanun V, Sahassanada D, Rajanuwong A, Pitisuttithum P, Howe PA, Smith MD, White NJ. Development and evaluation of a rapid urinary antigen detection test for diagnosis of Penicillium marneffei infection. J Clin Micro, 2002; 40: 3179-3183.
569. Dondorp AM, Nyanoti M, Kager PA, Mithwani S, Vreeken J, Marsh K. The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Trans R Soc Trop Med Hyg 2002; 96:282-6.
570. Dondorp AM. The treatment of severe malaria. Netherlands J Crit Care 2002; 6:28-31.
571. Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama WL, Ford N, White NJ. Malaria: current status of control, diagnosis and treatment, and a proposed R&D agenda. Lancet Infect Dis 2002; 2: 564-73.
572. Haataja L, McGready R, Arunjerdja R, Simpson JA, Mercuri E, Nosten F, Dubowitz L.A new approach for neurological evaluation of infants in resource-poor settings. Ann Trop Paediatr 2002; 22: 355-68.
573. Hastings I, Watkins WM, White NJ. Pharmacokinetic parameters affecting the evolution of drug-resistance in malaria; The role of the terminal elimination half-life. Philos Trans R Soc Lond B Biol Sci. 2002; 357: 505-19.
574. Leartsakulpanich U, Imwong M, Pukrittayakamee S, White NJ, SnounouG, Sirawaraporn W, Yuthavong Y.Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol Biochem Parasitol, 2002; 119: 63-73.
575. McGready R, Thwai KL, Samuel, Looareesuwan S, White NJ, Nosten F.The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Trans R Soc Trop Med Hyg, 2002; 96:180-4.
576. McGready R, Brockman A, Cho T, Levesque MA, Tkachuk AN, Meshnick SR, Nosten F. Haemozoin as a marker of placental parasitization. Trans R Soc Trop Med Hyg. 2002; 96: 644-6.
577. Nair S, Brockman A, Paiphun L, Nosten F, Anderson TJ. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. Int J Parasitol. 2002; 32: 852-8.
578. Newton P, Michelson G, Ruangveerayuth R, White NJ. Retinal haemorrhages in P.falciparum malaria. Lancet 2002; 360:515.
579. Newton P, White NJ, Rozendaal JA, Green MD. Murder by fake drugs.Brit Med J 2002; 324:800-801.
580. Newton P, van Vugt M, Teja-Isavadharm P, Siriyanonda D, Rasameesoroj M, Teerapong P, Ruangveerayuth R, Slight T, Nosten F, Suputtamongkol Y, Looareesuwan S, White NJ.Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria.Antimicrob Agents Chemother 2002; 46:1125-1127.
581. Newton PN, Thai LH, Tip NQ, Short JM, Chierakul W, Rajanuwong A, Pitisuttithum P, Chasombat S, Phonrat B, Maek-A-Nantawat W, Teaunadi R, Lalloo DG, White NJ. A randomised, double-blind, placebo-controlled trial of acetazolamide in the treatment of raised intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002; 35: 769-772.
582. Niumsup P, Wuthiekanun V. Cloning of the class D beta-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains. J Antimicrob Chemother 2002; 50:445-55.
583. Nontprasert A, Pukrittayakamee S, Prakongpan S, Supanaranond W, Looareesuwan S, White NJ. Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Trans R Soc Trop Med Hyg 2002; 96:99-101.
584. Nontprasert A, Pukrittayakamee S, Dondorp AM, Clemens R, Looareesuwan S, White NJ. Neuropathological toxicity of artemisinin derivatives in a mouse model. Am J Hyg Trop Med 2002; 67:423-429.
585. Nosten F, Brasseur P. Combination therapy for malaria: the way forward? Drugs. 2002; 62:1351-29.
586. Pukrittayakamee S, Pittisuttithum P, Zhang H, Jantra A, Wanwimolruk S, White NJ. Effects of cigarette smoking on quinine pharmacokinetics in malaria. Eur J Clin Pharmacol 2002; 58: 315-19.
587. Pukrittayakamee S, Krishna S, ter Kuile FO, Wilaiwan O, Williamson DH, White NJ. Alanine metabolism in acute falciparum malaria. Trop Med Int Hlth 2002; 7: 1-8.
588. Saengjaruk P, Chaicumpa W, Watt G, Bunyaraksyotin G, Wuthiekanun V, Tapchaisri P, Sittinont C, Panaphut T, Tomanakan K, Sakolvaree Y, Chongsa-Nguan M, Mahakunkijcharoen Y, Kalambaheti T, Naigowit P, Wambangco MA, Kurazono H, Hayashi H. Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J Clin Microbiol. 2002; 40:480-9.
589. Simpson JA, Aarons L, Collins WE, Jeffery G, White NJ. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology, 2002; 124: 247-63.
590. Simpson JA, Aarons L, Price R, White N J. The influence of body weight on the pharmacokinetics of mefloquine. Brit J Clin Pharmacol 2002: 53: 337-8.
591. Sonthayanon P, Krasao P, Wuthiekanun V, Panyim S, Tungpradabkul S. A simple method to detect and differentiate Burkholderia pseudomallei and Burkholderia thailandensis using specific flagellin gene primers. Mol Cell Probes. 2002; 16: 217-22.
592. Taylor WR, White NJ. Malaria and the lung. Clin Chest Med 2002; 23: 457-68.
593. Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, Newbold C, White N J. Febrile temperatures induce cytoadherence of ring stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci (USA), 2002; 99:11825-9.
594. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clin Infect Dis 2002; 35:1498-1504.
595. White NJ. The assessment of antimalarial drug resistance. Trends Parasitol, 2002; 18:458-464.
596. White NJ. Plasmodium species (Malaria). In V.Yu, R Weber, & D Raoult eds. Antimicrobial Therapy and Vaccines. Apple Trees productions LLC, 2nd edition; 2002, pp 1609-1634.
597. White NJ. Salmonella typhi (typhoid fever) and S.paratyphi (paratyphoid fever). In V.Yu, R Weber, & D Raoult eds. Antimicrobial Therapy and Vaccines. Apple Trees productions LLC, 2nd edition; 2002, pp 583-604.
598. White NJ, Simpson AJH. Burkholderia pseudomallei (melioidosis) and B.mallei (glanders). In V.Yu, R Weber, & D Raoult eds. Antimicrobial Therapy and Vaccines. Apple Trees productions LLC, 2nd edition; 2002, pp 149-156.
599. White NJ, Simpson AJH. Burkholderia species: Melioidosis and glanders. In V. Yu, TC Merigan, SL Barriere eds. Antimicrobial Chemotherapy and Vaccines. 2nd edition Williams & Wilkins, Baltimore, 2002, in press.
600. Wuthiekanun V, Anuntagool N, White NJ, Srisinha S. A rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia Thailandensis. Am J Trop Med Hyg, 2002; 66:759-76.
601. Chaorattanakawee S, Natalang O, Hananantachai H, Nacher M, Brockman A, Nosten F, Looareesuwan S, Patarapotikul J. Trichuris trichiura infection is associated with the multiplicity of Plasmodium falciparum infections in Thailand. Ann Trop Med Parasitol 2003; 97:199-202.
602. Chaorattanakawee S, Natalang O, Hananantachai H, Nacher M, Brockman A, Krudsood S, Looareesuwan S, Patarapotikul J.Storage duration and polymerase chain reaction detection of Plasmodium falciparum from blood spots on filter paper. Am J Trop Med Hyg. 2003 ;69: 42-4.
603. Davis TM, Supanaranond W, Pukrittayakamee S, Silamut K, White NJ. Evidence for continued two-brood replication of Plasmodium falciparum in vivo during quinine treatment. Acta Trop. 2003; 89:41-5.
604. Dondorp AM, Omodeo-Sale F, Chotivanich K, Taramelli D, White NJ. Oxidative stress and rheology in severe malaria. Redox Rep. 2003; 8:292-4.
605. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt BG. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol. 2003; 41:2068-79.
606. Imwong M, Pukrittayakamee S, Renia L, Letourneur F, Charlieu JP, Leartsakulpanich U, Looareesuwan S, White NJ, Snounou G.Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.Antimicrob Agents Chemother, 2003; 47:1514-1521.
607. Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ. Early Origin and Recent Expansion of Plasmodium falciparum. Science. 2003; 300: 318-21.
608. Lindegardh N, Ashton M, Bergqvist Y. Automated solid-phase extraction method for the determination of piperaquine in whole blood by rapid liquid chromatography. Ther Drug Monit. 2003; 25:544-51.
609. Luxemburger C, White NJ, ter Kuile FO, Singh HM, Allier-Frachon I, Ohn M, Chongsuphajaisiddhi T, Nosten F. Beri-beri: the major cause of infant mortality in Karen refugees. Trans R Soc Trop Med Hyg 2003; 97:251-255.
610. Mayxay M, Newton P, Khanthavong M, Pongvongsa T, Phetsouvanh R, Samlane PS, Brockman A, White NJ. Chloroquine versus sulphadoxine-pyrimethamine treatment of falciparum malaria in Savannakhet province, Lao PDR; an assessment of national antimalarial drug recommendations. Clin Infect Dis 2003; 37:1021-1028.
611. Mayxay M, Phetsouvanh R, Phompida S, Newton PN, Khanthavong M, Vannachone B, Brockman White NJ. A randomised comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Lao PDR (Laos). Trans R Soc Trop Med Hyg 2003; 97:343-4.
612. McGready R, Stepniewska K, Seaton E, Cho T, Cho D, Ginsberg A, Edstein MD, Ashley E, Looareesuwan S, White NJ, Nosten F. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharmacol 2003; 59:553-557.
613. McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 2003; 59:545-552.
614. McGready R, Simpson JA, Arunjerdja R, Golfetto I, Ghebremeskel K, Taylor A, Siemieniuk A, Mercuri E, Harper G, Dubowitz L, Crawford M, Nosten F. Delayed visual maturation in Karen refugee infants.
Ann Trop Paediatr. 2003; 23:193-204.
615. McGready R, Keo NK, Villegas L, White NJ, Looareesuwan S, Francois N. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg. 2003; 97:592-4.
616. Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003; 188:844-9.
617. Nacher M, McGready R, Stepniewska K, Thein Cho, Looareesuwan S, White NJ, Nosten F. Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Trans R Soc Trop Med Hyg; 2003; 97:273-6.
618. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ. A selective sweep driven by pyrimethamine treatment in SE Asian malaria parasites. Mol Biol Evol 2003; 20: 1526-1536.
619. Newton PN, Chierakul W, Ruangveerayuth R, Abhigantaphand D, Looareesuwan S, White NJ. Malaria and amphetamine ‘horse tablets’ in Thailand. Trop Med Int Hlth 2003; 8:17-18.
620. Newton PN, Angus BJ, Chierakul W, Dondorp AM, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ.A randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 2003; 37:7-16.
621. Newton P, Dondorp A, Green M, Mayxay M, White NJ. Counterfeit artesunate antimalarials in SE Asia. Lancet 2003; 362: 169.
622. Newton P. Counterfeit artesunate antimalarial tablets. WHO Pharmaceuticals Newsletter 2003; 3: 9.
623. Nosten F, McGready R, Looareesuwan S, White NJ. Editorial: Maternal malaria: time for action. Trop Med Int Health; 2003; 8: 485-7.
624. Nosten F, McGready R. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. J Infect Dis. 2003; 188:1259-61; author reply 1561-2.
625. Pattanasin, S., S. Proux, D. Chompasuk, K. Luwiradaj, P. Jacquier, L. S, and F. Nosten. Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. Trans R Soc Med Hyg 2003; 97:1-3.
626. Pongponratn E, Turner GDH, Day NPJ, Phu NH, Simpson JA, Stepniewska K, Mai NTH, Viriyavejakul P, Looareesuwan S, Hien TT, Ferguson DJP, White NJ. An ultrastructural study of the brain in fatal falciparum malaria. Am J Trop Med Hyg 2003; 69:345-359.
627. Pukrittyakamee S, Sompol Prakongpan, Sompol Wanwimolruk, Ralf Clemens, Sornchai Looareesuwan, Nicholas J. White. Adverse effect of rifampicin on quinine efficacy in uncomplicated falciparum malaria.Antimicrob Agents Chemother 2003; 47: 1509-13.
628. Pukrittayakamee S, Wanwimolruk S, Stepniewska K, Jantra A,Huyakorn S, Looareesuwan S White NJ. Quinine pharmacokinetic pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother 2003; 47:3458-3463.
629. Serirom S, Raharjo WH, Chotivanich K, Loareesuwan S, Kubes P, Ho M. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol. 2003; 162:1651-60.
630. Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg. 2003; 69: 14-8.
631. Silamut K, Newton PN, Teja-Isavadharm P, Suputtamongkol Y, Siriyanonda D, Rasameesoraj M, Pukrittayakamee S, White NJ. Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2003; 47:3795-8.
632. Simpson AJ, Newton PN, Chierakul W, Chaowagul W, White NJ. Diabetes mellitus, insulin, and melioidosis in Thailand. Clin Infect Dis. 2003; 36: e71-2.
633. Soukaloun D, Kounnavong S, Pengdy B, Boupha B, Durondej S, Olness K, Newton P, White NJ.Dietary and socioeconomic factors associated with infantile beri beri in breastfed Lao infants.Ann Trop Pae Int’l Child Hlth 2003; 23:181-186.
634. White NJ, Pongtavornpinyo W. The de-novo selection of drug resistance in malaria parasites. Proc R Soc Lond. B 2003; 270:545-554.
635. White NJ. The management of severe falciparum malaria. Am J Respir Crit Care Med 2003; 167:673-674.
636. White NJ. Melioidosis. Lancet; 2003; 361: 1715-1722.
637. White NJ. Malaria. In RG Finch, D Greenwood, R Norrby & R Whitely eds. Antibiotic and Chemotherapy. 8th edition.Harcourt Publishers Ltd, London 2003, pp 876-899.
638. White NJ. Malaria. In GC Cook, A Zumla eds: Manson's Tropical Diseases. 21st edition. London:WB Saunders, 2003, pp 1205-1296.
639. White NJ, Hien TT. Diphtheria. In GC Cook, A Zumla eds: Manson's Tropical Diseases. 21st edition. London:WB Saunders, 2003; pp 1137-1142.
2004
640. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004; 363:9-17.
641. Ashley E, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan L, Nosten F, White NJ. Dose optimisation randomized controlled studies ofdihydroartemisinin-piperaquine for the treatment of uncomplicated multi-drug resistant falciparum malaria in Thailand. J Infect Dis 2004; 190: 1773-82.
642. Ashley, E., R. McGready, S. Proux, and F. Nosten.Malaria. In J. Zuckerman (ed.), Essentials in Travel Medicine. 2004. Wiley.
643. Ashley, E., and F. Nosten. Management of Multiple Drug-Resistant Malaria, p.319-39. In S. H. Gillespie (ed.), Management of Multi Drug-Resistant Infections. 2004 Humana Press Inc, Totowa, NJ.
644. Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH, McGready R, Fletcher KA, Owens S, D'Alessandro U, Nosten F, Fischer PR, Ordi J. The sick placenta-the role of malaria. Placenta. 2004; 25:359-78.
645. Brockman A, Singlam S, Phiaphun L, Looareesuwan S, White NJ, and Nosten F. Field evaluation of a novel colorimetric method--double-site enzyme-linked lactate dehydrogenase immunodetection assay--to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand. Antimicrob Agents Chemother 2004; 48:1426-9.
646. Brouwer AE, Rajanuwong A, Chierakul W et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 2004; 363:1764-7.
647. Chaisavaneeyakorn S, Kongtawelert P, Angkasekwinai P, McGready R, Nosten F, Chairoj S. Inhibitory activities of sulfated proteoglycans on chondroitin sulfate A-mediated cytoadherence of plasmodium falciparum from Thailand. American Journal of Tropical Medicine & Hygiene 2004;70:149-157.
648. Checchi, F., P. Piola, C. Kosack, E. Ardizzoni, D. Klarkowski, E. Kwezi, G. Priotto, S. Balkan, N. Bakyaita, A. Brockman, and J. P. Guthmann. Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop Med Int Health 2004; 9:445-50.
649. Cheng AC, Day NPJ, Mayo MJ, Gal D, Currie BJ. Burkholderia pseudomallei strain type, based on pulsed field gel electrophoresis, does not determine disease presentation in melioidosis. Microbes and Infection 2004; in press.
650. Chierakul W, de Fost M, Suputtamongkol Y, Limpaiboon R, Dondorp AM, White NJ, van der Poll T. Differential expression of interferon-y and interferon-y-inducing cytokines in Thai patients with scrub typhus or leptospirosis. Clinical Immunology. 2004; 113:140-144
651. Chierakul W, Rajanuwong A, Wuthiekanun V, Teerawattanasook N, Gasiprong M, Simpson A, Chaowagul W, White NJ. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg; 2004; 98: 678-686.
652. Chotivanich K, Sritabal J, Udomsangpetch R, Newton P, Stepniewska KA, Ruangveerayuth R, Looareesuwan S, Roberts DJ, White NJ. Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis 2004; 189:1052-5.
653. Chotivanich K, Udomsangpetch R, Chierakul W, Newton PN, Pukrittayakamee S, Ruangveerayuth R, Looareesuwan S, White NJ. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am J Trop Med Hyg 2004; 70:395-7.
654. Day NPJ. Cerebral malaria. In: Emerging infections of the brain. Eds Power C & Johnson RT. Marcel Dekker Inc., New York. 2004; in press.
655. Dondorp AM, Pongponratn E, and White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop 2004; 89:309-17.
656. Dondorp AM, Chau TT, Phu NH, Mai NT, Loc PP, Chuong LV, Sinh DX, Taylor A, Hien TT, White NJ, Day NP. Unidentified acids of strong prognostic significance in severe malaria. Crit Care Med. 2004; 32:1683-1688.
657. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health. 2004; 9:1241-6.
658. Fausta Omodeo-Sale, Anna Motti, Arjen Dondorp, Nicholas J White and Donatella Taramelli Destabilization and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur J Haematol 2004; in press.
659. Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Sharp S, Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG and Parkhill J.Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 2004; 101:9786-91.
660. Holden MTG, Titball RW, Peacock SJ, Cerdeño-Tárraga AM, Atkins T, Crossman LC, Pitt T, Churcher C, Mungall K, Bentley SD, Sebahia M, Thomson NR, Bason N, Beacham IR, Brooks K, Brown K, Brown NF, Cherevach I, Chillingworth T, Cronin A, Davis P DeShazer D, Feltwell T, Fraser A, Hance Z, Hauser H, Holroyd S, Jagels K, Maddison M, Moule S Price1, M. A. Quail1, E. Rabbinowitsch1, K. Rutherford1, . Sanders1, M. Simmonds1, S. Songsivilai C, Stevens K, Tumapa S, Vesaratchavest M, Whitehead S, Yeats C, Barrell BG, Oyston PCF and Parkhill J. Genomic plasticity of Burkholderia pseudomallei, the causative agent of melioidosis.PNAS 2004; 101:14240-5
661. Joet T, Chotivanich K, Silamut K, Patel AP, Morin C, Krishna S. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor. Biochem J. 2004; 381:905-9.
662. Lindegårdh N, Annerberg A, Blessborn D, Bergqvist Y, Day NP, White NJ. Development and validation of a bioanalytical method using automated solid phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. J Pharmaceut Biomed Anal 2004; in press.
663. Malm M, Lindegardh N, Bergqvist Y. Automated solid-phase extraction method for the determination of piperaquine in capillary blood applied onto sampling paper by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 809:43-9.
664. Mayxay M, Newton PN, Yeung S, Pongvongsa T, Phompida S, Phetsouvanh R, White NJ. Short communication: An assessment of the use of malaria rapid tests by village health volunteers in rural Laos. Trop Med Int Health 2004; 9:325-9.
665. Mayxay M, Pukrittayakamee S, Newton PN, and White NJ. Mixed-species malaria infections in humans. Trends Parasitol 2004; 20:233-40.
666. Mayxay M, Newton PN, Khanthavong M, Tiengkham P, Phetsouvanh R, Phompida S, Brockman A, White NJ. Monitoring antimalarial efficacy.Clin Infect Dis, 2004; 38: 1193.
667. Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M,Pongvongsa T,YapomR, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN. Randomized comparison of chloroquine plus sulphadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao PDR (Laos). Clin Infect Dis 2004;39: 1139-47.
668. McGready R, Davison BB, Stepniewska K, Chot T, Shee H, Brockman A, Udomsangpetch R, Looareesuwan S, White NJ, Meshnick SR, Nosten F. The effects of Plasmodium falciparum and P.vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg 2004; 70:398-407.
669. McGready, R., E. Ashley, and F. Nosten. Malaria in the pregnant traveller. Travel Medicine and Infectious Diseases 2004 in press.
670. Myint HY, Tipmanee P, Nosten F, Pukrittayakamee S, Day NPJ, Looareesuwan S, White NJ. A systematic overview of published antimalarial drug trials. Trans R Soc Trop Med Hyg; 2004; 98:73-81.
671. Nacher M, Carrara VI, Ashley E, McGready R, Hutagalung R, Nguen JV, Thwai KL, Looareesuwan S, Nosten F. Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border. Trans R Soc Trop Med Hyg. 2004; 98:322-8.
672. Nacher M, Carrara VI, McGready R, Ashley E, Nguen JV, Thwai KL, Looareesuwan S, Nosten F. Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand. Ann Trop Med Parasitol. 2004; 98:115-20.
673. Newton P, Essien E, White NJ. Platelets and blood coagulation in human malaria. In: The Haematology of malaria, eds. G Pasvol and S Abdalla. Imperial College Press, London. June 2004.
674. Newton PN The hazards of counterfeit antimalarials. Bull Oriental Bird Club 2004.
675. Nosten F, Ashley E. The detection and treatment of Plasmodium falciparum malaria: time for change. J Postgrad Med. 2004; 50:35-9.
676. Nosten, F., S. J. Rogerson, J. G. Beeson, R. McGready, T. K. Mutabingwa, and B. Brabin. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 2004; 20:425-432.
677. Peacock SJ, Staphylococcus. Topley and Wilson Microbiology and Microbial Infections. 10th edition 2004. Arnold Publishers. In press.
678. Peacock SJ. Staphylococcus aureus. Principles and Practice of Clinical Bacteriology, 2nd Edition 2004, John Wiley In press.
679. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004; 364:438-47.
680. Pukrittayakamee S, Imwong M, Looareesuwan S, and White NJ. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 2004; 89:351-6.
681. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, and White NJ. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 2004; 48:1329-34.
682. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004; 305:1124.
683. Snounou G and White NJ. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 2004; 20:333-9.
684. Smithuis F, van der Broek I, Katterman I, Kyaw MK, Brockman A, Lwin S, White NJ. Optimising operational use of artesunate-mefloquine; a randomised comparison of four treatment regimens. Trans R Soc Trop Med Hyg; 2004; 98:182-92.
685. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar. Trop Med Int Health 2004; 9:1184-90.
686. Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, Wuthiekanun V, Triengrim S, Chenchittikul M, White NJ. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis. 2004; 39:1417-24.
687. Suwanarusk R, Cooke BM, Dondorp AM, Silamut K, Sattabongkot J, White NJ, Udomsangpetch R. The Deformability of Red Blood Cells Parasitized by Plasmodium falciparum and P. vivax. J Infect Dis 2004; 189:190-4.
688. Stepniewska K, Taylor WRJ, Mayxay M, Price R, Smithuis F, Guthmann J-P, Barnes K, Myint H, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NPJ, White NJ. In vivo assessment of Drug Efficacy against Plasmodium falciparum Malaria; Duration of Follow-Up. Antimicrob Agents Chemother 2004; 48:4271-4280.
689. Taylor WR, White NJ.Antimalarial drug toxicity. Drug Safety 2004; 27:25-61.
690. Teja-Isavadharm P, Peggins JO, Brewer TG, White NJ, Webster HK, Kyle DE. A Plasmodium falciparum bioassay for measurement of artemisinin derivatives in plasma or serum.Antimicrob Agents Chemother, 2004; 48:954-960.
691. van den Broek, I. V., S. van der Wardt, L. Talukder, S. Chakma, A. Brockman, S. Nair, and T. C. Anderson. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh. Trop Med Int Health 2004; 9:680-7.
692. White NJ. Malaria. In V.Yu, TC Merigan, & SL Barriere eds. Antimicrobial Therapy and Vaccines. Williams & Wilkins, Baltimore; 2nd edition; in press.
693. White NJ, Breman JG. Diseases caused by red blood cell parasites; Malaria and Babesiosis. In:Kasper DL, Braunwald E, Fauci AS, Hauser SL, Jameson JL eds. Harrison's Principles of Internal Medicine. 16th edition. New York: McGraw?Hill Inc., 2004, in press.
694. White NJ, Nosten F, Bjorkman A, Marsh K, Snow RW. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004; 363:1160.
695. White NJ. Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: sulfadoxine-pyrimethamine is not working in Malawi. BMJ. 2004; 328: 1259.
696. White NJ, Breman JG. Diseases caused by red blood cell parasites; Malaria and Babesiosis. In:Kasper DL, Braunwald E, Fauci AS, Hauser SL, Jameson JL eds. Harrison's Principles of Internal Medicine. 16th edition. New York: McGraw?Hill Inc., 2004, in press.
697. White NJ. Antimalarial drug resistance. J Clin Invest 2004; 113:1084-92.
698. White NJ. Sharing malarias. Lancet 2004; 363:1006.
699. White NJ. Cerebral Malaria. Practical Neurology, 2004; 4:20-29.
700. Wuthiekanun V, Amornchai P, Chierakul W, Cheng AC, White NJ, Peacock SJ, Day NP. Evaluation of Immunoglobulin M (IgM) and IgG Rapid Cassette Test Kits for Diagnosis of Melioidosis in an Area of Endemicity. J Clin Microbiol. 2004; 42:3435-7.
701. Yeung S, Pongtavornpinyo W, Hastings I, Mills AJ, White NJ. Antimalarial drug resistance, artemisinin based combination therapy (ACT), and the contribution of modelling to elucidating policy choices. Am J Trop Med Hyg, 2004; 71 (Sup 2): 179-86.
702. Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, Nosten F. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother. 2005; 49: 2180-8.
703. Anderson TJ, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Tran TH, van dB, IV, White NJ, Nosten F. Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Mol Biol Evol. 2005; 22: 2362-74.
704. Annerberg A, Singtoroj T, Tipmanee P, White NJ, Day NP, Lindegardh N. High throughput assay for the determination of lumefantrine in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 822: 3303.
705. Ashley EA, White NJ. Artemisinin-based combinations. Curr Opin Infect Dis. 2005; 18: 531-6.
706. Ashley EA, McGready R, Hutagalung R, Phaiphun L, Slight T, Proux S, Thwai KL, Barends M, Looareesuwan S, White NJ, Nosten F. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis. 2005; 41: 425-32.
707. Barnes KI, White NJ. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 2005; 94: 230-40.
708. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2005; 2: e330.
709. Bowden MG, Chen W, Singvall J, Xu Y, Peacock SJ, Valtulina V, Speziale P, Hook M. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology. 2005; 151: 1453-64.
710. Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS. Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis. 2005; 192: 681-4.
711. Buckling A, Neilson J, Lindsay J, ffrench-Constant R, Enright M, Day N, Massey RC. Clonal distribution and phase-variable expression of a major histocompatibility complex analogue protein in Staphylococcus aureus. J Bacteriol. 2005; 187: 2917-9.
712. Carrara VI, Nosten F: Associations medicamenteuses dans le traitement du paludisme-le role des dérivés de l'artemisinine. La Lettre de l'Infectiologue. 2005; 20: 172-178.
713. Chaowagul W, Chierakul W, Simpson AJ, Short JM, Stepniewska K, Maharjan B, Rajchanuvong A, Busarawong D, Limmathurotsakul D, Cheng AC, Wuthiekanun V, Newton PN, White NJ, Day NP, Peacock SJ. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother. 2005; 49: 4020-5.
714. Cheng AC, Day NP, Mayo MJ, Gal D, Currie BJ. Burkholderia pseudomallei strain type, based on pulsed-field gel electrophoresis, does not determine disease presentation in melioidosis. Microbes Infect. 2005; 7: 104-9.
715. Chierakul W, Wuthiekanun V, Chaowagul W, Amornchai P, Cheng AC, White NJ, Day NP, Peacock SJ. Disease severity and outcome of melioidosis in HIV coinfected individuals. Am J Trop Med Hyg. 2005; 73: 1165-6.
716. Chierakul W, Winothai W, Wattanawaitunechai C, Wuthiekanun V, Rugtaengan T, Rattanalertnavee J, Jitpratoom P, Chaowagul W, Singhasivanon P, White NJ, Day NP, Peacock SJ. Melioidosis in 6 tsunami survivors in southern Thailand. Clin Infect Dis. 2005; 41: 982-90.
717. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, Limmathurotsakul D, Cheng AC, Stepniewska K, Newton PN, Chaowagul W, White NJ, Peacock SJ, Day NP, Chetchotisakd P. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis. 2005; 41: 1105-13.
718. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005; 2: e100.
719. Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ. Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005; 99: 517-24.
720. Dondorp A, Nosten F, Stepniewska K, Day N, White N and South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005; 366: 9487, 717-25.
721. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005; 2: e204.
722. Fisher MC, Hanage WP, de Hoog S, Johnson E, Smith MD, White NJ, Vanittanakom N. Low effective dispersal of asexual genotypes in heterogeneous landscapes by the endemic pathogen Penicillium marneffei. PLoS Pathog. 2005; 1: e20.
723. de Fost M, Chierakul W, Pimda K, Dondorp AM, White NJ, van Der PT. Activation of cytotoxic lymphocytes in patients with scrub typhus. Am J Trop Med Hyg. 2005; 72: 465-7.
724. Fowler VG, Jr., Justice A, Moore C, Benjamin DK, Jr., Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005; 40: 695-703.
725. Gupta RK, van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate. Am J Trop Med Hyg. 2005; 73: 267-8.
726. Huis in ‘t Veld, V, Wuthiekanun V, Cheng AC, Chierakul W, Chaowagul W, Brouwer AE, White NJ, Day NP, Peacock SJ. The role and significance of sputum cultures in the diagnosis of melioidosis. Am J Trop Med Hyg. 2005; 73: 657-61.
727. Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malar J. 2005; 4: 46.
728. Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother. 2005; 49: 4393-5.
729. Krudsood S, Imwong M, Wilairatana P, Pukrittayakamee S, Nonprasert A, Snounou G, White NJ, Looareesuwan S. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. Trans R Soc Trop Med Hyg. 2005; 99: 142-9.Nash D, Nair S, Mayxay M, Newton PN, Guthmann JP, Nosten F, Anderson TJ. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci. 2005; 272: 1153-61.
730. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, White NJ, Snounou G. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005; 4: 20.
731. Kumkhaek C, Phra-Ek K, Renia L, Singhasivanon P, Looareesuwan S, Hirunpetcharat C, White NJ, Brockman A, Gruner AC, Lebrun N, Alloueche A, Nosten F, Khusmith S, Snounou G. Are extensive T cell epitope polymorphisms in the Plasmodium falciparum circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? J Immunol. 2005; 175: 3935-9.
732. Limmathurotsakul D, Wuthiekanun V, Chierakul W, Cheng AC, Maharjan B, Chaowagul W, White NJ, Day NP, Peacock SJ. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol. 2005; 43: 2274-6.
733. Lindegardh N, Blessborn D, Bergqvist Y. Simultaneous quantitation of the highly lipophilic atovaquone and hydrophilic strong basic proguanil and its metabolites using a new mixed-mode SPE approach and steep-gradient LC. J Chromatogr Sci. 2005; 43: 259-66.
734. Lindegardh N, Annerberg A, Blessborn D, Bergqvist Y, Day N, White NJ. Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. J Pharm Biomed Anal. 2005; 37: 1081-8.
735. Lindegardh N, White NJ, Day NP. High throughput assay for the determination of piperaquine in plasma. J Pharm Biomed Anal. 2005.
736. Lindegardh N, Singtoroj T, Annerberg A, White NJ, Day NP. Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma. Ther Drug Monit. 2005; 27: 503-8.
737. McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, Looareesuwan S, White NJ, Nosten F. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis. 2005; 192: 846-53.
738. Maharjan B, Chantratita N, Vesaratchavest M, Cheng A, Wuthiekanun V, Chierakul W, Chaowagul W, Day NP, Peacock SJ. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol. 2005; 43: 6032-4.
739. Medana IM, Lindert RB, Wurster U, Hien TT, Day NP, Phu NH, Mai NT, Chuong LV, Chau TT, Turner GD, Farrar JJ, White NJ. Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria. Trans R Soc Trop Med Hyg. 2005; 99: 610-7.
740. Nacher M, McGready R, Lermoo C, Wichiponpiboon J, Nosten F. Photoallergy to quinine. Trop Doct. 2005; 35: 117-8.
741. Newton PN, Chaulet JF, Brockman A, Chierakul W, Dondorp A, Ruangveerayuth R, Looareesuwan S, Mounier C, White NJ. Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria. Antimicrob Agents Chemother. 2005; 49: 1622-5.
742. Newton PN, Day NP, White NJ. Misattribution of central nervous system dysfunction to artesunate. Clin Infect Dis. 2005; 41: 1687-8.
743. Nosten F. Malaria control in Plasmodium falciparum resistant to multi-therapy: A field opinion. Med Trop (Mars). 2005; 65: 91-2.
744. Nosten F, McGready R, Ashley E, White NJ. Malaria misconceptions. Lancet. 2005; 365: 653.
745. Omodeo-Sale F, Motti A, Dondorp A, White NJ, Taramelli D. Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur J Haematol. 2005; 74: 324-32.
746. Peacock SJ, Chieng G, Cheng AC, Dance DA, Amornchai P, Wongsuvan G, Teerawattanasook N, Chierakul W, Day NP, Wuthiekanun V. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol. 2005; 43: 5359-61.
747. Phongmany S, Phetsouvanh R, Sisouphone S, Darasavath C, Vongphachane P, Rattanavong O, Mayxay M, Ramsay AC, Blacksell SD, Thammavong C, Syhavong B, White NJ, Newton PN. A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. Trans R Soc Trop Med Hyg. 2005; 99: 451-8.
748. Prommano O, Chaisri U, Turner GD, Wilairatana P, Ferguson DJ, Viriyavejakul P, White NJ, Pongponratn E. A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malaria. Southeast Asian J Trop Med Public Health. 2005; 36: 1359-70.
749. Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, Sheldon J, Chierakul W, Peacock S, Day N, White NJ, Harrison TS. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol. 2005; 174: 1746-50.
750. Tarning J, Lindegardh N, Annerberg A, Singtoroj T, Day NP, Ashton M, White NJ. Pitfalls in estimating piperaquine elimination. Antimicrob Agents Chemother. 2005; 49: 5127-8.
751. Tiyawisutsri R, Peacock SJ, Langa S, Limmathurotsakul D, Cheng AC, Chierakul W, Chaowagul W, Day NP, Wuthiekanun V. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay. J Clin Microbiol. 2005; 43: 4872-4.
752. Urban BC, Hien TT, Day NP, Phu NH, Roberts R, Pongponratn E, Jones M, Mai NT, Bethell D, Turner GD, Ferguson D, White NJ, Roberts DJ. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun. 2005; 73: 1986-1994.
753. Wattanawaitunechai C, Peacock SJ, Jitpratoom P. Tsunami in Thailand--disaster management in a district hospital. N Engl J Med. 2005; 352: 962-4.
754. Wuthiekanun V, Mayxay M, Chierakul W, Phetsouvanh R, Cheng AC, White NJ, Day NP, Peacock SJ. Detection of Burkholderia pseudomallei in soil within the Lao People's Democratic Republic. J Clin Microbiol. 2005; 43: 923-4.
755. Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, Simpson AJ, Short JM, Wongsuvan G, Maharjan B, White NJ, Peacock SJ. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005; 55: 1029-31.
756. Wuthiekanun V, Desakorn V, Wongsuvan G, Amornchai P, Cheng AC, Maharjan B, Limmathurotsakul D, Chierakul W, White NJ, Day NP, Peacock SJ. Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol. 2005; 12: 555-6.
757. White NJ, Breman JG. Malaria and Babesiosis; Diseases caused by red blood cell parasites. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds: Harrison's Principles of Internal Medicine. 16th edition. 2005. New York: McGraw?Hill Inc. pp: 1218-32.
758. White NJ, Silamut K. Postmortem brain smear assessment of fatal malaria. J Infect Dis. 2005; 192: 547.
759. White NJ. Dynamic determinants of the cytoadherence of Plasmodium falciparum-infected erythrocytes. Am J Trop Med Hyg. 2005; 72: 658-9.
760. White NJ. Intermittent presumptive treatment for malaria. PLoS Med. 2005; 2: e3.
761. Yeung S, White NJ. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005; 10: 121-38.